Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00087022
Protocol Section: NCT00087022
Start Identification Module Data
Brief Title: Monoclonal Antibody Therapy Rencarex in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
Official Title: A Randomized Double Blind Phase III Study To Evaluate Adjuvant cG250 Treatment Versus Placebo In Patients With Clear Cell RCC And High Risk of Recurrence ARISER
Acronym: None
Organization: Heidelberg Pharma AG
Organization Class: INDUSTRY
Organization Study ID: WX-2003-07-HR
Secondary IDs
Secondary ID Type Domain Link
NCI-2012-00491 REGISTRY CTRP Clinical Trials Reporting System None
WILEX-WX-2003-07-HR OTHER None None
ARISER OTHER None None
UCLA-0404015-01 OTHER None None
CDR0000372830 REGISTRY None None
Start Status Module Data
Status Verified Date: 2018-10
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Heidelberg Pharma AG
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Heidelberg Pharma AG
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload